• Vanguards of Health Care by Bloomberg Intelligence

  • By: Bloomberg
  • Podcast

Vanguards of Health Care by Bloomberg Intelligence

By: Bloomberg
  • Summary

  • Vanguards of Health Care is a series of exclusive conversations with management teams and thought leaders discussing changes on the forefront of the industry, including innovations in medical products and technologies, advances in clinical research, new service models, wellness and regulations.

    2024 Bloomberg
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Delfi Looks to Build Off of FirstLook
    Nov 21 2024

    “Our mission is to make cancer less deadly through widely accessible next-generation early-detection blood tests.” Susan Tousi, CEO of Delfi Diagnostics, tells Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. Tousi joins BI analyst Jonathan Palmer to discuss the company’s fragment-based liquid biopsy technology and the immense opportunity to save lives through early cancer detection. Starting with lung cancer via its FirstLook test, Delfi expects to expand more broadly into other cancer types and applications like monitoring with a focus on access and affordability. The conversation touches on the company’s core values and the large opportunity set afforded by recent funding rounds.

    See omnystudio.com/listener for privacy information.

    Show more Show less
    58 mins
  • Insulet Sees Long Ramp Treating Type 2 Diabetes with Omnipod 5
    Nov 14 2024

    Insulet’s Omnipod 5 automated insulin delivery (AID) system has avenues to expand as it’s revolutionized the way patients treat their diabetes, including the new indication for Type 2 diabetes, CEO Jim Hollingshead explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Hollingshead sits down with BI analyst Matt Henriksson for an in-depth interview on Insulet’s Omnipod patch pump technology, how on-the-body wear compares to traditional insulin pumps and opens access to patients still using syringes, and expansion opportunities with Omnipod 5 in international markets and with the Type 2 diabetic cohort in the US.Find this and other Bloomberg Intelligence podcasts at BI PODCASTS .

    See omnystudio.com/listener for privacy information.

    Show more Show less
    52 mins
  • Reimagining Early Stage Investing with Define Ventures
    Nov 7 2024

    “When I looked at the industry, I saw a real opportunity set to build a best-in-class sector-focused fund,” Lynne Chou O’Keefe, founder and managing partner of Define Ventures, tells Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. O’Keefe joins BI analyst Jonathan Palmer for a deep discussion into Define’s unique approach to health-care investing, emphasizing the importance of both health-care and tech expertise. The two discuss the major trends shaping health care, including technology, consumerization and the evolution of the value chain. The podcast concludes with insights into the state of the market, including valuations, IPOs and potential consolidation.

    See omnystudio.com/listener for privacy information.

    Show more Show less
    55 mins

What listeners say about Vanguards of Health Care by Bloomberg Intelligence

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.